Fig. 2
From: Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer
Prognostic function of evaluation and inner validation. (A) Survival difference between low-risk and high-risk patients, ***P < 0.001. (B) Prediction accuracy of the risk signature. (C) Expression difference of ten genes between low-risk group and high-risk group. (D) Survival status difference between low-risk and high-risk patients. (E) Risk score value difference between alive and dead patients, ***P < 0.001. (F and G) Survival difference and its corresponding AUC value in inner validation set 1, **P < 0.01. (H and I) Survival difference and its corresponding AUC value in inner validation set 2, ***P < 0.001